235 related articles for article (PubMed ID: 25315681)
21. Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication.
Flierl A; Oliveira LM; Falomir-Lockhart LJ; Mak SK; Hesley J; Soldner F; Arndt-Jovin DJ; Jaenisch R; Langston JW; Jovin TM; Schüle B
PLoS One; 2014; 9(11):e112413. PubMed ID: 25390032
[TBL] [Abstract][Full Text] [Related]
22. Identifying Therapeutic Agents for Amelioration of Mitochondrial Clearance Disorder in Neurons of Familial Parkinson Disease.
Yamaguchi A; Ishikawa KI; Inoshita T; Shiba-Fukushima K; Saiki S; Hatano T; Mori A; Oji Y; Okuzumi A; Li Y; Funayama M; Imai Y; Hattori N; Akamatsu W
Stem Cell Reports; 2020 Jun; 14(6):1060-1075. PubMed ID: 32470327
[TBL] [Abstract][Full Text] [Related]
23. Nitration of microtubules blocks axonal mitochondrial transport in a human pluripotent stem cell model of Parkinson's disease.
Stykel MG; Humphries K; Kirby MP; Czaniecki C; Wang T; Ryan T; Bamm V; Ryan SD
FASEB J; 2018 Oct; 32(10):5350-5364. PubMed ID: 29688812
[TBL] [Abstract][Full Text] [Related]
24. Genetic and environmental findings in early-onset Parkinson's disease Brazilian patients.
Aguiar Pde C; Lessa PS; Godeiro C; Barsottini O; Felício AC; Borges V; Silva SM; Saba RA; Ferraz HB; Moreira-Filho CA; Andrade LA
Mov Disord; 2008 Jul; 23(9):1228-33. PubMed ID: 18464276
[TBL] [Abstract][Full Text] [Related]
25. Parkin maintains mitochondrial levels of the protective Parkinson's disease-related enzyme 17-β hydroxysteroid dehydrogenase type 10.
Bertolin G; Jacoupy M; Traver S; Ferrando-Miguel R; Saint Georges T; Grenier K; Ardila-Osorio H; Muriel MP; Takahashi H; Lees AJ; Gautier C; Guedin D; Coge F; Fon EA; Brice A; Corti O
Cell Death Differ; 2015 Oct; 22(10):1563-76. PubMed ID: 25591737
[TBL] [Abstract][Full Text] [Related]
26. The mitochondrial protein BNIP3L is the substrate of PARK2 and mediates mitophagy in PINK1/PARK2 pathway.
Gao F; Chen D; Si J; Hu Q; Qin Z; Fang M; Wang G
Hum Mol Genet; 2015 May; 24(9):2528-38. PubMed ID: 25612572
[TBL] [Abstract][Full Text] [Related]
27. The TOMM machinery is a molecular switch in PINK1 and PARK2/PARKIN-dependent mitochondrial clearance.
Bertolin G; Ferrando-Miguel R; Jacoupy M; Traver S; Grenier K; Greene AW; Dauphin A; Waharte F; Bayot A; Salamero J; Lombès A; Bulteau AL; Fon EA; Brice A; Corti O
Autophagy; 2013 Nov; 9(11):1801-17. PubMed ID: 24149440
[TBL] [Abstract][Full Text] [Related]
28. Parkinson's disease-associated VPS35 mutant reduces mitochondrial membrane potential and impairs PINK1/Parkin-mediated mitophagy.
Ma KY; Fokkens MR; Reggiori F; Mari M; Verbeek DS
Transl Neurodegener; 2021 Jun; 10(1):19. PubMed ID: 34127073
[TBL] [Abstract][Full Text] [Related]
29. SLP-2 interacts with Parkin in mitochondria and prevents mitochondrial dysfunction in Parkin-deficient human iPSC-derived neurons and Drosophila.
Zanon A; Kalvakuri S; Rakovic A; Foco L; Guida M; Schwienbacher C; Serafin A; Rudolph F; Trilck M; Grünewald A; Stanslowsky N; Wegner F; Giorgio V; Lavdas AA; Bodmer R; Pramstaller PP; Klein C; Hicks AA; Pichler I; Seibler P
Hum Mol Genet; 2017 Jul; 26(13):2412-2425. PubMed ID: 28379402
[TBL] [Abstract][Full Text] [Related]
30. Variable PARK2 Mutations Cause Early-Onset Parkinson's Disease in a Small Restricted Population.
Ben-Shachar S; Afawi Z; Masalha R; Badarny S; Neiman T; Pavzner D; Bar-Shira A; Orr-Urtreger A
J Mol Neurosci; 2017 Oct; 63(2):216-222. PubMed ID: 28913705
[TBL] [Abstract][Full Text] [Related]
31. Generation of induced pluripotent stem cells, KCi004-A derived from a male with Parkinson's disease and homozygous for the PINK1 variant c.1366C > T, p.Gln456.
Jonsgaard Larsen L; Birk Møller L
Stem Cell Res; 2023 Sep; 71():103175. PubMed ID: 37524028
[TBL] [Abstract][Full Text] [Related]
32. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
Büeler H
Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
[TBL] [Abstract][Full Text] [Related]
33. Evaluating Manganese, Zinc, and Copper Metal Toxicity on SH-SY5Y Cells in Establishing an Idiopathic Parkinson's Disease Model.
Pradhan SH; Liu JY; Sayes CM
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003318
[TBL] [Abstract][Full Text] [Related]
34. A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2.
Kay DM; Stevens CF; Hamza TH; Montimurro JS; Zabetian CP; Factor SA; Samii A; Griffith A; Roberts JW; Molho ES; Higgins DS; Gancher S; Moses L; Zareparsi S; Poorkaj P; Bird T; Nutt J; Schellenberg GD; Payami H
Neurology; 2010 Sep; 75(13):1189-94. PubMed ID: 20876472
[TBL] [Abstract][Full Text] [Related]
35. Perturbations in RhoA signalling cause altered migration and impaired neuritogenesis in human iPSC-derived neural cells with PARK2 mutation.
Bogetofte H; Jensen P; Okarmus J; Schmidt SI; Agger M; Ryding M; Nørregaard P; Fenger C; Zeng X; Graakjær J; Ryan BJ; Wade-Martins R; Larsen MR; Meyer M
Neurobiol Dis; 2019 Dec; 132():104581. PubMed ID: 31445161
[TBL] [Abstract][Full Text] [Related]
36. Identification of mutations in the PARK2 gene in Serbian patients with Parkinson's disease.
Jankovic MZ; Dobricic V; Kresojevic N; Markovic V; Petrovic I; Svetel M; Pekmezovic T; Novakovic I; Kostic V
J Neurol Sci; 2018 Oct; 393():27-30. PubMed ID: 30099245
[TBL] [Abstract][Full Text] [Related]
37.
Wauters F; Cornelissen T; Imberechts D; Martin S; Koentjoro B; Sue C; Vangheluwe P; Vandenberghe W
Autophagy; 2020 Feb; 16(2):203-222. PubMed ID: 30945962
[TBL] [Abstract][Full Text] [Related]
38. Heterozygote carriers for CNVs in PARK2 are at increased risk of Parkinson's disease.
Huttenlocher J; Stefansson H; Steinberg S; Helgadottir HT; Sveinbjörnsdóttir S; Riess O; Bauer P; Stefansson K
Hum Mol Genet; 2015 Oct; 24(19):5637-43. PubMed ID: 26188007
[TBL] [Abstract][Full Text] [Related]
39. Stress-induced precocious aging in PD-patient iPSC-derived NSCs may underlie the pathophysiology of Parkinson's disease.
Zhu L; Sun C; Ren J; Wang G; Ma R; Sun L; Yang D; Gao S; Ning K; Wang Z; Chen X; Chen S; Zhu H; Gao Z; Xu J
Cell Death Dis; 2019 Feb; 10(2):105. PubMed ID: 30718471
[TBL] [Abstract][Full Text] [Related]
40. Interaction between Parkin and
Madsen DA; Schmidt SI; Blaabjerg M; Meyer M
Cells; 2021 Jan; 10(2):. PubMed ID: 33572534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
